USFDA issues warning letter to Cipla for Goa manufacturing facility

Drug firm Cipla Ltd said that the US health regulator has issued a
warning letter to the company for its manufacturing facility in Goa.
The company further said that it remains committed to maintain highest
standards of compliance and will work closely with the agency to
comprehensively address all the observations.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-letter-to-cipla-for-goa-manufacturing-facility/articleshow/74312928.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny